Related references
Note: Only part of the references are listed.Structural Plasticity of Dopaminergic Neurons Requires the Activation of the D3R-nAChR Heteromer and the PI3K-ERK1/2/Akt-Induced Expression of c-Fos and p70S6K Signaling Pathway
Veronica Mutti et al.
MOLECULAR NEUROBIOLOGY (2022)
The Signaling and Pharmacology of the Dopamine D1 Receptor
Jace Jones-Tabah et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2022)
Bivalent ligands promote endosomal trafficking of the dopamine D3 receptor-neurotensin receptor 1 heterodimer
Julian Budzinski et al.
COMMUNICATIONS BIOLOGY (2021)
Dopamine D1
Pengfei Yang et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)
Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders
Bela Kiss et al.
BIOMOLECULES (2021)
Evidence for Protein-Protein Interaction between Dopamine Receptors and the G Protein-Coupled Receptor 143
Beatriz Bueschbell et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Expression of Melatonin and Dopamine D3 Receptor Heteromers in Eye Ciliary Body Epithelial Cells and Negative Correlation with Ocular Hypertension
Irene Reyes-Resina et al.
CELLS (2020)
β-arrestin 2 quenches TLR signaling to facilitate the immune evasion of EPEC
Zijuan Chen et al.
GUT MICROBES (2020)
Modulation of dopamine D-1 receptors via histamine H-3 receptors is a novel therapeutic target for Huntington's disease
David Moreno-Delgado et al.
ELIFE (2020)
Dopamine D3 Receptor Heteromerization: Implications for Neuroplasticity and Neuroprotection
Federica Bono et al.
BIOMOLECULES (2020)
From cell lines to pluripotent stem cells for modelling Parkinson's Disease
Elena Ferrari et al.
JOURNAL OF NEUROSCIENCE METHODS (2020)
BDNF Overexpression Increases Striatal D3 Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia
Simona Scheggi et al.
JOURNAL OF PARKINSONS DISEASE (2020)
5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction
Silvia Fanni et al.
NEUROBIOLOGY OF DISEASE (2019)
Biased G Protein-Independent Signaling of Dopamine D1-D3 Receptor Heteromers in the Nucleus Accumbens
Xavier Guitart et al.
MOLECULAR NEUROBIOLOGY (2019)
Receptor-Receptor Interactions as a Widespread Phenomenon: Novel Targets for Drug Development?
Diego Guidolin et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Cross-communication between Gi and Gs in a G-protein-coupled receptor heterotetramer guided by a receptor C-terminal domain
Gemma Navarro et al.
BMC BIOLOGY (2018)
Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticity
Leonardo Bontempi et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
Conformational biosensors reveal allosteric interactions between heterodimeric AT1 angiotensin and prostaglandin F2α receptors
Rory Sleno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
An update on the physiological and therapeutic relevance of GPCR oligomers
Batoul Farran
PHARMACOLOGICAL RESEARCH (2017)
The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling
Yuri K. Peterson et al.
PHARMACOLOGICAL REVIEWS (2017)
D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia
Doris E. Payer et al.
NEUROLOGY (2016)
G Protein-Coupled Receptor Heteromers
Ivone Gomes et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 (2016)
Quaternary structures of opsin in live cells revealed by FRET spectrometry
Ashish K. Mishra et al.
BIOCHEMICAL JOURNAL (2016)
Quaternary structure of a G-protein-coupled receptor heterotetramer in complex with Gi and Gs
Gemma Navarro et al.
BMC BIOLOGY (2016)
Shp-2 knockdown prevents l-dopa-induced dyskinesia in a rat model of Parkinson's disease
Chiara Fiorentini et al.
MOVEMENT DISORDERS (2016)
Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia
Daniel Farre et al.
MOLECULAR NEUROBIOLOGY (2015)
β-Arrestin 2 Negatively Regulates Toll-like Receptor 4 (TLR4)-triggered Inflammatory Signaling via Targeting p38 MAPK and Interleukin 10
Hui Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Heteromeric Dopamine Receptor Signaling Complexes: Emerging Neurobiology and Disease Relevance
Melissa L. Perreault et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Structural plasticity in mesencephalic dopaminergic neurons produced by drugs of abuse: critical role of BDNF and dopamine
Ginetta Collo et al.
FRONTIERS IN PHARMACOLOGY (2014)
Functional Selectivity of Allosteric Interactions within G Protein-Coupled Receptor Oligomers: The Dopamine D1-D3 Receptor Heterotetramer
Xavier Guitart et al.
MOLECULAR PHARMACOLOGY (2014)
Persistent activation of the D1R/Shp-2/Erk1/2 pathway in L-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease
Chiara Fiorentini et al.
NEUROBIOLOGY OF DISEASE (2013)
Orphan Receptor GPR179 Forms Macromolecular Complexes With Components of Metabotropic Signaling Cascade in Retina ON-Bipolar Neurons
Cesare Orlandi et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
Interactions between NMDA and dopamine receptors: A potential therapeutic target
Min Wang et al.
BRAIN RESEARCH (2012)
Pre-synaptic dopamine D3 receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways
Ginetta Collo et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Apo-Ghrelin Receptor Forms Heteromers with DRD2 in Hypothalamic Neurons and Is Essential for Anorexigenic Effects of DRD2 Agonism
Andras Kern et al.
NEURON (2012)
Dopamine D1-histamine H3 Receptor Heteromers Provide a Selective Link to MAPK Signaling in GABAergic Neurons of the Direct Striatal Pathway
Estefana Moreno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The tyrosine phosphatase Shp-2 interacts with the dopamine D1 receptor and triggers D1-mediated Erk signaling in striatal neurons
Chiara Fiorentini et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Signaling Pathways Leading to Phosphorylation of Akt and GSK-3 beta by Activation of Cloned Human and Rat Cerebral D-2 and D-3 Receptors
Clotilde Mannoury la Cour et al.
MOLECULAR PHARMACOLOGY (2011)
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
Jean-Martin Beaulieu et al.
PHARMACOLOGICAL REVIEWS (2011)
The Dopamine D1-D2 Receptor Heteromer Localizes in Dynorphin/Enkephalin Neurons INCREASED HIGH AFFINITY STATE FOLLOWING AMPHETAMINE AND IN SCHIZOPHRENIA
Melissa L. Perreault et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Schizophrenia, amphetamine-induced sensitized state and acute amphetamine exposure all show a common alteration: increased dopamine D2 receptor dimerization
Min Wang et al.
MOLECULAR BRAIN (2010)
The D3 dopamine receptor inhibits dopamine release in PC-12/hD3 cells by autoreceptor signaling via PP-2B, CK1, and Cdk-5
Pei-Chun Chen et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth
Ahmed Hasbi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Selective Antagonism at Dopamine D3 Receptors as a Target for Drug Addiction Pharmacotherapy: A Review of Preclinical Evidence
Christian Heidbreder
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2008)
Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation
Ginetta Collo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Identification of dopamine D1-D3 receptor heteromers -: Indications for a role of synergistic D1-D3 receptor interactions in the striatum
Daniel Marcellino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization
Chiara Fiorentini et al.
MOLECULAR PHARMACOLOGY (2008)
An essential function for β-arrestin 2 in the inhibitory signaling of natural killer cells
Ming-Can Yu et al.
NATURE IMMUNOLOGY (2008)
Allosteric transinhibition by specific antagonists in CCR2/CXCR4 heterodimers
Denis Sohy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Do orphan G-protein-coupled receptors have ligand-independent functions? New insights from receptor heterodimers
Angelique Levoye et al.
EMBO REPORTS (2006)
The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer
Koji Takahashi et al.
CANCER RESEARCH (2006)
Validation of the L-dopa-induced dyskinesia in the 6-OHDA model and evaluation of the effects of selective dopamine receptor agonists and antagonists
C Monville et al.
BRAIN RESEARCH BULLETIN (2005)
Adenosine A2A receptor and dopamine D3 receptor interactions:: Evidence of functional A2A/D3 heteromeric complexes
M Torvinen et al.
MOLECULAR PHARMACOLOGY (2005)
Interactions of GIPC with dopamine D2, D3 but not D4 receptors define a novel mode of regulation of G protein-coupled receptors
F Jeanneteau et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
D1 dopamine receptor mediates dopamine-induced cytotoxicity via the ERK signal cascade
J Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Histamine H3 receptor activation inhibits dopamine D1 receptor-induced cAMP accumulation in rat striatal slices
E Sánchez-Lemus et al.
NEUROSCIENCE LETTERS (2004)
Comparative studies of molecular mechanisms of dopamine D2 and D3 receptors for the activation of extracellular signal-regulated kinase
SR Beom et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Agonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D2 receptor
VD Nair et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Dual inhibition of β-adrenergic and angiotensin II receptors by a single antagonist -: A functional role for receptor-receptor interaction in vivo
L Barki-Harrington et al.
CIRCULATION (2003)
D2/D3 dopamine receptor heterodimers exhibit unique functional properties
M Scarselli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies
E Bezard et al.
NATURE REVIEWS NEUROSCIENCE (2001)
The role and regulation of adenosine in the central nervous system
TV Dunwiddie et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats
R Bordet et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
Shp-2 specifically regulates several tyrosine-phosphorylated proteins in brain-derived neurotrophic factor signaling in cultured cerebral cortical neurons
T Araki et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Share Paper
